{"meshTags":["Duodenal Neoplasms","Antineoplastic Combined Chemotherapy Protocols","Antigens, CD30","Cyclophosphamide","Prednisolone","Lymphoma, Large B-Cell, Diffuse","Middle Aged","Doxorubicin","Male","Vincristine","Humans"],"meshMinor":["Duodenal Neoplasms","Antineoplastic Combined Chemotherapy Protocols","Antigens, CD30","Cyclophosphamide","Prednisolone","Lymphoma, Large B-Cell, Diffuse","Middle Aged","Doxorubicin","Male","Vincristine","Humans"],"genes":["CD30","Ki-1","Ki-1","Ki-1","Ki-1"],"organisms":["9606"],"publicationTypes":["Case Reports","Journal Article","Review"],"abstract":"As recently described, Ki-1 anaplastic large cell lymphoma is a distinctive subtype of non-Hodgkin\u0027s lymphoma. We report a Ki-1 anaplastic large cell lymphoma of the duodenum in a 62-year-old man. He received modified CHOP therapy and was in complete remission at 18 months. To our knowledge, this is the first report of primary Ki-1 anaplastic large cell lymphoma of the duodenum.","title":"Case report: primary CD30 (Ki-1)-positive anaplastic large cell lymphoma of the duodenum.","pubmedId":"9011440"}